Skip to main content

Month: May 2021

Philips Foundation publishes its 2020 Annual Report highlighting the deployment of health technology expertise for underserved communities

philips-foundation-published- its-2020-annual-reportrapid-deployment-intensive-care-unit-in-bergamo-italyfostering-local-healthcare-innovation-in-kenyatransforming-primary-healthcare-ecosystems-from-the-inside-outMay 4, 2021 75 successful projects rolled out, including over 40 activities dedicated to combatting COVID-19 in 2020 Over 7.5 million people in underserved communities provided with access to healthcare in 2020 A global community of social entrepreneurs nurtured through development and scaling of sustainable models that provide affordable access to quality healthcareAmsterdam, the Netherlands – Philips Foundation, with its mission to provide access to quality healthcare for underserved communities through meaningful innovation, today announced publication...

Continue reading

On received court claim

On received court claim and adopted interim measures AB “Ignitis grupė” (hereinafter – the Company) informs that on 4 May 2021 it received information that Vilnius District Prosecutor’s Office (hereinafter – the Prosecutor) applied to Vilnius District Court (hereinafter – the Court) with a claim related to the decisions of the Company’s General Meeting of Shareholders and Management Board in respect of employee and executive incentive with share options plans implemented by the Company and invalidation of option agreements as well as request for application of interim measures (hereinafter – IM). IM were applied by the Court order on 3 May 2021, which, in principle, has suspended the employee stock ownership plan as well as executive long-term incentive with share options plan until the Court decision in respect of this case takes effect. According...

Continue reading

On received court claim and adopted interim measures

AB “Ignitis grupė” (hereinafter – the Company) informs that on 4 May 2021 it received information that Vilnius District Prosecutor’s Office (hereinafter – the Prosecutor) applied to Vilnius District Court (hereinafter – the Court) with a claim related to the decisions of the Company’s General Meeting of Shareholders and Management Board in respect of employee and executive incentive with share options plans implemented by the Company and invalidation of option agreements as well as request for application of interim measures (hereinafter – IM). IM were applied by the Court order on 3 May 2021, which, in principle, has suspended the employee stock ownership plan as well as executive long-term incentive with share options plan until the Court decision in respect of this case takes effect. According to the assessment of the Company, employee...

Continue reading

MT Højgaard Holding A/S: MT Højgaard Danmark wins turnkey contract for construction of office complex in Nordhavn

MT Højgaard Holding’s business unit, MT Højgaard Danmark, has been awarded a turnkey contract for the construction of a large office complex in Nordhavn in Copenhagen. The contract’s value amounts to DKK 1.589 billion. The turnkey contract includes project design and construction of an office complex of 56,500 square meters of floor space, which will serve as domiciles for AP Pension Livsforsikringsaktieselskab and Nykredit A/S as well as a multi-user house and common basement of 17,500 square meters. The developer is K/S Svanemølleholm, which is a company in the AP Pension group. Work will be initiated in May 2021, and the project will be completed in two phases. The construction work for Nykredit incl. basement has to be completed at the end of June 2023, and the domicile for AP Pension as well as the multi-user house have to be completed...

Continue reading

Proactive news headlines including Arrow Minerals, Archer Materials, MGC Pharmaceuticals and Meteoric Resources

Sydney, May 04, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Arrow Minerals Ltd (ASX:AMD) has received commitments from qualified sophisticated and professional investors to raise $3 million through the issue of 500 million shares at 6 cents per share. Click here Archer Materials Ltd’s (ASX:AXE) (OTCMKTS:ARRXF) (FRA:38A) shares are trading about 5% higher intra-day after executing a new quantum computing agreement with International Business Machines Corporation (NYSE:IBM). Click here MGC Pharmaceuticals Ltd (ASX:MXC) (LON:MXC) (OTCMKTS:MGCLF) has received a new wholesale purchase order of ArtemiC Rescue from Swiss PharmaCan AG (SPC) worth about €640,000 (A$1 million). Click here Meteoric Resources NL (ASX:MEI) is...

Continue reading

Core One Labs Completes Milestone Acquisition of Akome Biotech

VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to announce that it has completed the acquisition (the “Transaction”) of Akome Biotech Ltd. (“Akome”). With this strategic acquisition, the scope of Core One’s psychedelics’ bio-pharma research and development division will broaden to include drug formulations that effectively target and change underlying processes at the root of neurological disorders, and/or prevent further neurological damage that result from the disorders. What distinguishes Akome’s approach from other companies focused on the psychedelic treatment of neurological...

Continue reading

Change in Enedo Plc’s Executive Management Team

ENEDO PLC   Stock Exchange Release     4.5.2021  at 9:45 Change in Enedo Plc’s Executive Management Team Olli Mustonen, Enedo’s Chief Financial Officer (CFO) and a member of the Executive Management Team, has resigned to move to new challenges outside Enedo. He will continue in his current position and as a member of the Executive Management Team for the time being, however, until the end of August 2021 at the latest. “Olli’s contribution to the changes in Enedo’s business operations and to the planning and implementation of financing activities over the past three years has been completely invaluable. Olli has been an integral part of planning and starting Enedo’s turnaround plan. I want to already now thank Olli for his excellent work and wish him success in the future with his own entrepreneurial path”,...

Continue reading

CORRECTION: Vistin Pharma ASA : Key information relating to the cash dividend

This is a correction of the announcement from 30.04.2021, 11:22 CEST. Reason for the correction: Change of record date. Vistin Pharma ASA : Key information relating to the cash dividend to be paid by Vistin Pharma ASA Dividend amount: NOK 0.5 Declared currency: NOK Last day including right: 20 May 2021 Ex-date: 21 May 2021 Record date: 25 May 2021 Payment date: 3 June 2021 Date of approval: 20 May 2021For further information, please contact: Alexander Karlsen CFO +47 97 05 36 21 alexander.karlsen@vistin.comThis information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.  

Continue reading

Changed result for fiscal year 2020/21

To Nasdaq OMX Copenhagen A/S Public announcement no. 494 May 4, 2021 2020/21 RESULTS EXPECTED TO EXCEED THE GUIDANCE IN GLUNZ & JENSEN HOLDING A/S Glunz & Jensen announces that the expectations for 2020/21 have been revised. Glunz & Jensen has had a better-than-expected result for 2020/21, primarily due to a strong fourth quarter and because the positive effects of the consolidation of activities in Glunz & Jensen (Slovakia) have materialized earlier than expected. The full year revenue for 2020/21, which ended March 31, 2021, is expected to be approximately 137 MDKK. The previous outlook was at 130-140 MDKK for the full year 2020/21. The EBITDA before non-recurring items and fair value adjustment on investment properties is expected to be approximately 19 MDKK. It was previously communicated in the range of DKK 12-14...

Continue reading

Interim Financial Report of Jyske Realkredit A/S, Q1 2021

Jyske Realkredit A/S – Interim Financial Report, Q1 2021 To NASDAQ Copenhagen A/S                                                                                                                  4 May 2021                                                                                                                 Announcement No. 46/2021 Interim Financial Report of Jyske Realkredit A/S, Q1 2021 On May 4, 2021 the Board of Directors has approved the Interim Financial Report of Jyske Realkredit A/S, Q1 2021. Please see attached file. Yours sincerely,Jyske Realkredit A/S Carsten Tirsbæk MadsenCEO Direct phone (+45) 89 89 90 50E-mail: ctm@jyskerealkredit.dk Web: jyskerealkredit.dk Please observe that the Danish version of this announcement prevails. Attached files:Interim Financial report of Jyske Realkredit, Q1 2021.pdfAttachment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.